SPI-BIO

Welcome to the Brand page for “SPI-BIO”, which is offered here for [ pharmaceutical products for use in the treatment of cardiological, neurological and neurovirological disorders; pharmaceutical products with anti-retro viral properties and immuinomodulators and used for tile treatment of aids, prion diseases, cancer, endocrinology disorders, and immune disorders ];reagents for scientific, research and medical research uses; diagnostic reagents for scientific or research use;[ pharmacology research in cardiology, neurology and neurovirology; pharmacology research in vivo and in vitro relating to molecules with anti-retro viral properties and to immunomodulators; human and animal pharmacokinetic research and metabolism research; bioavallability and bioequivalence research;research on pharmacokinetic and metabolic models;research services, development of dosage and measurement of medicated molecules; production of new chemical entities and metabolites by bio transformation;evaluation of microbiological safety with regard to infectious agents; immunossay and enzyme immunoassay development for pharmaceutical products and endogenous substances ];.

Its status is currently believed to be active. Its class is unavailable. “SPI-BIO” is believed to be currently owned by “BERTIN PHARMA”.